DEMIR OSMANOVIC: Open Payments
NPI 1508538224 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 9 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $79 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Almatica Pharma LLC | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: Auvelity, INVEGA SUSTENNA, LOREEV XR, REXULTI, INGREZZA, UZEDY, VRAYLAR, HETLIOZ.
Industry payments across SC — which companies pay providers there.
